Follow the 메디톡스 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 메디톡스 has published 78 insider filings. Market capitalisation: €554bn. The latest transaction was filed on 2 April 2026 (Purchase). Among the most active insiders: 정현호. All data is free.
78
Insider Decl.
0
Thresholds
·
16 ops.
Buy Volume
·
2 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 13,416 of 26,212 companies
51.2
score / 100
Value
48
Quality
54
FCF yld5.6%
Earn yld3.4%
EV/EBITDA20.5x
ROE4.8%
Gross mgn58%
Net mgn6.7%
Debt/EBITDA2.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.